GLIVIN–M 2 Composition: GLIMEPIRIDE 2 MG + METFORMIN 500 MG SR (Sustained Release)

Overview: Glivin–M 2 is a bilayered tablet combining two key antidiabetic medications – Glimepiride and Metformin. This synergistic formulation is designed to provide effective blood sugar control in individuals with type 2 diabetes.

Key Components:

  1. Glimepiride (2 mg): A sulfonylurea medication that stimulates the pancreas to produce insulin, helping lower blood sugar levels.
  2. Metformin (500 mg SR): A biguanide that improves insulin sensitivity, reduces glucose production in the liver, and slows glucose absorption in the intestines. The sustained-release formulation ensures a gradual release over time.

Uses: Glivin–M 2 is prescribed for the following purposes:

  1. Type 2 Diabetes Management: The combination of Glimepiride and Metformin targets different aspects of blood sugar regulation, providing comprehensive control in individuals with type 2 diabetes.
  2. Improved Insulin Sensitivity: Metformin enhances the body’s response to insulin, making it more effective in lowering blood glucose levels.
  3. Reduced Hepatic Glucose Production: Metformin suppresses glucose production in the liver, a common issue in diabetes.

How to Use:

  • Take Glivin–M 2 exactly as prescribed by your healthcare provider.
  • Swallow the tablet whole with a glass of water, typically with meals.
  • Follow your healthcare provider’s instructions for dosage adjustments and frequency.
  • Adhere to a healthy diet and exercise regimen as recommended by your healthcare provider.

Possible Side Effects: While Glivin–M 2 is generally well-tolerated, individuals may experience some side effects, including:

  1. Hypoglycemia: Low blood sugar levels, particularly if meals are skipped or inadequate.
  2. Gastrointestinal Distress: Common with Metformin, symptoms may include nausea, vomiting, or diarrhea.
  3. Weight Gain: A potential side effect of sulfonylureas like Glimepiride.

It is important to report any persistent or severe side effects to your healthcare provider promptly.


  • Inform your healthcare provider about your medical history, existing conditions, and current medications.
  • Regularly monitor blood sugar levels as directed by your healthcare provider.
  • Avoid excessive alcohol consumption, as it can enhance the risk of hypoglycemia.

Note: This information serves as a general guide. Consult your healthcare provider for personalized advice and to address specific concerns related to Glivin–M 2. Never self-prescribe or adjust your dosage without professional guidance




There are no reviews yet.

Be the first to review “GLIVIN PM 2”

Your email address will not be published. Required fields are marked *